Consequently, people who can afford to do so are approaching private providers for access to these medicines despite the potential risks to their health
Heres what to know before getting started
For semaglutide, Novo Nordisk filed the composition patent in December 2003 (issued as US 8,927,488 in 2015), giving a base expiration of December 2023
Consider incorporating: Yogurt with live cultures Kefir Kimchi Sauerkraut Kombucha If constipation becomes a recurring issue, talk with your healthcare provider before relying on laxatives long term
Patients Seeking Sustained, Proven Efficacy: With 72-week and 3-year data available from SURMOUNT-1, Tirzepatide offers a well-established track record of sustained results
Garnier has served as a member of the board of directors of Carrier Global Corporation, a public company and as a member and chair of the board of directors of Cellectis S.A., a public biopharmaceutical company